These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11912816)

  • 21. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
    Gaede P; Vedel P; Larsen N; Jensen GV; Parving HH; Pedersen O
    N Engl J Med; 2003 Jan; 348(5):383-93. PubMed ID: 12556541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Other drug treatments: the evidence.
    Poulter N
    Proc Nutr Soc; 2000 Aug; 59(3):425-6. PubMed ID: 10997663
    [No Abstract]   [Full Text] [Related]  

  • 24. The natural history of diabetes-related complications: the UKPDS experience. United Kingdom Prospective Diabetes Study.
    Matthews DR
    Diabetes Obes Metab; 1999 Sep; 1 Suppl 2():S7-13. PubMed ID: 11221801
    [No Abstract]   [Full Text] [Related]  

  • 25. Self-monitoring of blood glucose--psychological aspects relevant to changes in HbA1c in type 2 diabetic patients treated with diet or diet plus oral antidiabetic medication.
    Siebolds M; Gaedeke O; Schwedes U;
    Patient Educ Couns; 2006 Jul; 62(1):104-10. PubMed ID: 16159705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CAPPP trial. Captopril Prevention Project.
    Messerli FH; Grossman E
    Lancet; 1999 May; 353(9166):1794-5; author reply 1795-6. PubMed ID: 10348012
    [No Abstract]   [Full Text] [Related]  

  • 27. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 28. Glucose lowering and cardiovascular disease: what do we know and what should we do?
    Cheng AY; Leiter LA
    Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S25-31. PubMed ID: 20489417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of type 2 diabetes.
    McFarlane SI; Shin JJ; Rundek T; Bigger JT
    Curr Diab Rep; 2003 Jun; 3(3):235-41. PubMed ID: 12762972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Insights into Pharmacologic Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus.
    Purga SL; Sidhu M; Farkouh M; Schulman-Marcus J
    Cardiovasc Drugs Ther; 2017 Aug; 31(4):459-470. PubMed ID: 28871349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
    Abraira C; Duckworth W; McCarren M; Emanuele N; Arca D; Reda D; Henderson W;
    J Diabetes Complications; 2003; 17(6):314-22. PubMed ID: 14583175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of antihypertensive therapy in type 2 diabetes.
    Hansson L
    Diabetes Obes Metab; 2000 Mar; 2 Suppl 1():S37-41. PubMed ID: 11225758
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on Hypertension Management: treatment of hypertension in patients with type 2 diabetes mellitus.
    Nilsson PM; Cifkova R; Kjeldsen SE
    J Hypertens; 2006 Jan; 24(1):208-10. PubMed ID: 16331123
    [No Abstract]   [Full Text] [Related]  

  • 34. The treatment of type 2 diabetes: good news from the UK.
    Smith RB; Mann JI
    N Z Med J; 1999 May; 112(1087):149-50. PubMed ID: 10378808
    [No Abstract]   [Full Text] [Related]  

  • 35. Intensive glycemic control and cardiovascular disease: an update.
    Brown A; Reynolds LR; Bruemmer D
    Nat Rev Cardiol; 2010 Jul; 7(7):369-75. PubMed ID: 20404853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antihypertensive therapy in type 2 diabetes mellitus.
    Miser WF
    J Fam Pract; 1998 Dec; 47(6):413-4. PubMed ID: 9866657
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry.
    Song J; Sheng CS; Huang QF; Li LH; Ma CS; Guo XH; Ji LN; Wang JG;
    J Hypertens; 2016 Aug; 34(8):1648-53. PubMed ID: 27270188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What matters in ADVANCE and ADVANCE-ON.
    Hamet P
    Diabetes Obes Metab; 2012 Jan; 14 Suppl 1():20-9. PubMed ID: 22118707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive treatment of patients with diabetes and hypertension.
    Julius S; Majahalme S; Palatini P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):310S-316S. PubMed ID: 11721889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.